NASDAQ:EIGR

Eiger BioPharmaceuticals, Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$1.73

+0 (+0%)

At Close: Apr 25, 2024

Currently predicting for Mon, 29 Apr 2024

Trading levels for EIGR

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	1.73	0.00000000 %
		R2	1.73	0.00000000 %
		R1	1.73	0.00000000 %
Current price:			1.73
	Support	S1	1.73	0.00000000 %
		S2	1.73	0.00000000 %
		S3	1.73	0.00000000 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	0	.
		R2	2.11	22.32 %
		R1	1.90	10.14 %
Current price			1.73
	Support	S1	1.65	-4.35%
		S2	1.39	-19.42%
		S3	1.30	-24.64%

EIGR Predictions History

4 years ago
JS predicted that EIGR for 2020-01-13 is going $13.60 (-0.73%)

4 years ago
NameNotImportant predicted that EIGR for 2019-05-06 is going $10.37 (-2.63%)

4 years ago
NameNotImportant predicted that EIGR for 2019-04-29 is going $10.91 (-0.37%)

About Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targe... EIGR Profile

Golden Star

Ticker	Date	Change	Price
MLI	Apr 19	11.73%	$52.28
LPLA	Apr 19	1.08%	$262.59
DOOR	Apr 18	0.274%	$131.39
LNG	Apr 17	1.63%	$156.81
FCN	Apr 16	3.70%	$207.62
ELV	Apr 16	6.45%	$506.97
AKR	Apr 05	5.14%	$16.53
ITCI	Apr 05	5.39%	$68.44
SARK	Mar 28	14.47%	$26.88
ARCC	Mar 25	2.53%	$20.12

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In